Docoh
Loading...

17 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q2
PCSA Processa Pharmaceuticals Inc
12 Aug 21
Quarterly report
4:01pm
on annual Net Sales, as defined in the Ocuphire Agreement. We are required to use commercially reasonable efforts, at our sole cost and expense to oversee
8-K
PCSA Processa Pharmaceuticals Inc
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
agreement it may enter into. Processa is required to use commercially reasonable efforts, at its sole cost and expense to oversee such commercialization
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
into. In conjunction with a joint Processa-Yuhan Board to oversee commercialization efforts, we are required to use commercially reasonable efforts, at our sole cost
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
Processa-Yuhan Board to oversee such commercialization efforts, we are required to use commercially reasonable efforts, at our sole cost and expense
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
agreement we may enter into. In conjunction with a joint Processa-Yuhan Board to oversee such commercialization efforts, we are required to use … are required to use commercially reasonable efforts, at our sole cost and expense, in conjunction with a joint Processa-Yuhan Board to oversee
10-Q
2020 Q3
PCSA Processa Pharmaceuticals Inc
12 Nov 20
Quarterly report
4:01pm
cost and expense, in conjunction with a joint Processa-Yuhan Board to oversee such commercialization efforts, to research, develop and commercialize … , at our sole cost and expense, in conjunction with a joint Processa-Yuhan Board to oversee such commercialization efforts, to research, develop
8-K
EX-1.1
PCSA Processa Pharmaceuticals Inc
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
-in periods specified in the applicable stock exchange rules (the “Exchange Rules”), validly appointed an audit committee to oversee internal accounting
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
with a joint Processa-Yuhan Board to oversee such commercialization efforts, to research, develop and commercialize products in one or more countries
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
with a joint Processa-Yuhan Board to oversee such commercialization efforts, to research, develop and commercialize products in one or more countries
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
with a joint Processa-Yuhan Board to oversee such commercialization efforts, to research, develop and commercialize products in one or more countries
S-1/A
EX-10.4
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
by providing timely and accurate analysis of budgets, financial trends and forecasts. direct and oversee all aspects of the finance & Accounting functions … and mitigate key elements of the company’s risk profile. report risk issues to the CEO and audit committee of the Board of Directors. oversee the SEC
S-1/A
EX-1.1
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
in the applicable stock exchange rules (the “Exchange Rules”), validly appointed an audit committee to oversee internal accounting controls whose composition
S-1/A
EX-10.11
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
after the Effective Date, the Parties will establish a Processa Yuhan Advisory Board (the “PCYU Board”) to oversee and coordinate the Parties … ’ activities under this Agreement to the extent provided in this Agreement. The PCYU Board shall: (i) oversee the Development Plan to ensure that the goals
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
after the Effective Date, the Parties will establish a Processa Yuhan Advisory Board (the “PCYU Board”) to oversee and coordinate the Parties’ activities … under this Agreement to the extent provided in this Agreement. The PCYU Board shall: (i) oversee the Development Plan to ensure that the goals
8-K
PCSA Processa Pharmaceuticals Inc
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
reasonable efforts, at its sole cost and expense, in conjunction with a joint Processa-Yuhan Board to oversee such commercialization efforts, to research
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
9 Sep 18
Departure of Directors or Certain Officers
8:00pm
timely and accurate analysis of budgets, financial trends and forecasts. direct and oversee all aspects of the finance & Accounting functions … and mitigate key elements of the company’s risk profile. report risk issues to the CEO and audit committee of the Board of Directors. oversee the SEC financial
10-Q
2014 Q2
EX-10.1
PCSA Processa Pharmaceuticals Inc
18 Aug 14
Quarterly report
8:00pm
, and other key stakeholders to develop and implement financial, management, and growth strategies across the organization. As CFO, you will oversee all … responsibilities include: Finance Oversee cash flow planning and ensure availability of funds as needed. Oversee cash, investment, and asset
  • 1